Voyager Therapeutics, Inc. (VYGR)
2.175
-0.10
(-4.19%)
USD |
NASDAQ |
Oct 13, 11:20
Voyager Therapeutics EPS Diluted (Quarterly) : -0.4042 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4042 |
| March 31, 2026 | -0.4696 |
| December 31, 2025 | -0.4653 |
| September 30, 2025 | -0.4743 |
| June 30, 2025 | -0.569 |
| March 31, 2025 | -0.5316 |
| December 31, 2024 | -0.5949 |
| September 30, 2024 | -0.1563 |
| June 30, 2024 | -0.1757 |
| March 31, 2024 | -0.1984 |
| December 31, 2023 | 1.251 |
| September 30, 2023 | -0.5905 |
| June 30, 2023 | -0.5103 |
| March 31, 2023 | 2.942 |
| December 31, 2022 | -0.6129 |
| September 30, 2022 | 0.4454 |
| June 30, 2022 | -0.4984 |
| March 31, 2022 | -0.5603 |
| December 31, 2021 | 0.151 |
| September 30, 2021 | -0.6653 |
| June 30, 2021 | -0.8015 |
| March 31, 2021 | -0.5773 |
| December 31, 2020 | -0.4271 |
| Date | Value |
|---|---|
| September 30, 2020 | 2.272 |
| June 30, 2020 | -0.2344 |
| March 31, 2020 | -0.6564 |
| December 31, 2019 | -0.3414 |
| September 30, 2019 | -0.4084 |
| June 30, 2019 | 0.294 |
| March 31, 2019 | -0.8146 |
| December 31, 2018 | -0.697 |
| September 30, 2018 | -0.6303 |
| June 30, 2018 | -0.80 |
| March 31, 2018 | -0.6274 |
| December 31, 2017 | -0.40 |
| September 30, 2017 | -0.89 |
| June 30, 2017 | -0.73 |
| March 31, 2017 | -0.65 |
| December 31, 2016 | -0.57 |
| September 30, 2016 | -0.35 |
| June 30, 2016 | -0.37 |
| March 31, 2016 | -0.29 |
| December 31, 2015 | -0.67 |
| September 30, 2015 | -0.2581 |
| June 30, 2015 | -0.2519 |
| March 31, 2015 | -3.72 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.47M |
| Revenue (Quarterly) | 3.165M |
| Total Expenses (Quarterly) | 27.64M |
| Enterprise Value | 55.32M |
| Gross Profit Margin (Quarterly) | 71.31% |
| Profit Margin (Quarterly) | -773.2% |
| Earnings Yield | -83.37% |
| Normalized Earnings Yield | -83.37 |